Latest Sobi News & Updates

See the latest news and media coverage for Sobi. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Sobi

Biopharmaceutical company focused on rare diseases

sobi.com
Headquarters
Stockholm, Sweden
Company type
Public company
Number of employees
2,200–5,000

Last updated

Latest news about Sobi

In short: Sobi reported strong Q1 2026 growth, completed its $1.5 billion acquisition of Arthrosi Therapeutics, and set a 2030 revenue target of SEK 55 billion.

Company announcements

  • Sobi

    Sobi welcomes two new board members

    Åsa Riisberg and Mikael Dolsten were elected at the Annual General Meeting on 6 May 2026 and will strengthen governance and long-term strategy.

  • Sobi

    Sobi holds Annual General Meeting

    Shareholders approve financial statements, re-elect board members, approve remuneration, incentive programs, and share issuances. David Meek re-elected as chair.

  • Sobi

    Sobi maintains No. 2 position in patient engagement

    This marks the second consecutive year in PatientView's Global Corporate Reputation report. Sobi excels in patient centricity, safety, and integrity. Previously ranked No. 1 in Rare Disease Edition.

  • Sobi

    Sobi shares strong Q1 performance

    Driven by successful launches, pipeline progress, and regulatory submissions in Europe. CEO highlights commitment to rare disease treatments.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Sobi

Track Sobi and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Sobi competitors & trending companies

Browse news for competitors to Sobi and other trending companies.